Dose proportionality and BE [Design Issues]

posted by sciguy – Canada, 2011-11-04 20:18 (4977 d 04:32 ago) – Posting: # 7612
Views: 8,157

Hi Helmut,

❝ If you get a CI within 80–125% after 10 mg compare to 8 mg without dose-correction f is lower, right? It might be possible that (e.g. with an MR compared to an IR) you partly miss the absorption window of the drug. f will be lower.


You're right - I meant if f and clearance are different than it wouldn't be appropriate to dose normalize. In a properly designed study, it would seem unlikely clearance would be much different though since the strengths are similar.
Thanks for your input!

sciguy

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
43 visitors (0 registered, 43 guests [including 10 identified bots]).
Forum time: 01:51 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5